- Previous Close
14.86 - Open
14.99 - Bid 12.08 x --
- Ask 12.09 x --
- Day's Range
11.89 - 14.30 - 52 Week Range
10.65 - 19.20 - Volume
6,641,460 - Avg. Volume
4,221,654 - Market Cap (intraday)
1.971B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
27.48 - EPS (TTM)
0.44 - Earnings Date --
- Forward Dividend & Yield 0.15 (1.01%)
- Ex-Dividend Date May 23, 2024
- 1y Target Est
--
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; cardiovascular and inflammation; biochemistry kits; DNA methylation testing kits; and molecular detection of COVID-19 and others. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.
www.tellgen.comRecent News: 300642.SZ
View MorePerformance Overview: 300642.SZ
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300642.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300642.SZ
View MoreValuation Measures
Market Cap
2.42B
Enterprise Value
2.03B
Trailing P/E
34.11
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.22
Price/Book (mrq)
1.61
Enterprise Value/Revenue
4.39
Enterprise Value/EBITDA
29.21
Financial Highlights
Profitability and Income Statement
Profit Margin
15.32%
Return on Assets (ttm)
1.63%
Return on Equity (ttm)
4.25%
Revenue (ttm)
462.55M
Net Income Avi to Common (ttm)
70.88M
Diluted EPS (ttm)
0.44
Balance Sheet and Cash Flow
Total Cash (mrq)
476.68M
Total Debt/Equity (mrq)
5.42%
Levered Free Cash Flow (ttm)
5.99M